Matthew Pauls, Director: Soleno Therapeutics SLNO Sell · Filed 25/03/31

Trade details

Type: Insider sale
Amount: $424,792.35
Shares · price: 5,937 sh · $71.55 a share
Held after: 6,500 sh
Stock: Soleno Therapeutics SLNO
Person: Matthew PaulsDirector
Trade date: 25/03/28
Filed: 25/03/31
Days to filing: 3 days

Sold 47.7% of holdings

Share of holding sold: 47.7%

Soleno Therapeutics trades, last 26 weeks

What else happened in Soleno Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/26~25/04/27

Matthew Pauls's recent trades

Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$7,925
371 sh
$7,925
Filed 04/06
Traded 04/02
Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$8,516
415 sh
$8,516
Filed 04/06
Traded 04/02
Matthew PaulsCEO
SellSavara
Sell
Savara
SVRA
$181.1K
54,702 sh
$181.1K
Filed 24/12/16
Traded 24/12/16
Matthew PaulsCEO
SellSavara
Sell
Savara
SVRA
$395.6K
84,000 sh
$395.6K
Filed 23/12/29
Traded 23/12/28